MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Sep 2021 Evaluate
The company witnessed a 8.49% growth in the revenue at Rs. 1109.56 millions for the quarter ended June 2021 as compared to Rs. 1022.77 millions during the year-ago period.The Total Profit for the quarter ended June 2021 of Rs. 66.87 millions grew from Rs.-226.05 millionsThe company reported a degrowth in operating Profit to 130.74 millions from 145.54 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202106 202006 % Var
Sales 1109.56 1022.77 8.49 1109.56 1022.77 8.49 1109.56 1022.77 8.49
Other Income 6.89 6.91 -0.29 6.89 6.91 -0.29 6.89 6.91 -0.29
PBIDT 130.74 145.54 -10.17 130.74 145.54 -10.17 130.74 145.54 -10.17
Interest 4.82 2.54 89.76 4.82 2.54 89.76 4.82 2.54 89.76
PBDT 125.92 -180.51 -169.76 125.92 -180.51 -169.76 125.92 -180.51 -169.76
Depreciation 30.25 29.84 1.37 30.25 29.84 1.37 30.25 29.84 1.37
PBT 95.67 -210.35 -145.48 95.67 -210.35 -145.48 95.67 -210.35 -145.48
TAX 28.80 15.70 83.44 28.80 15.70 83.44 28.80 15.70 83.44
Deferred Tax -0.07 15.70 -100.45 -0.07 15.70 -100.45 -0.07 15.70 -100.45
PAT 66.87 -226.05 -129.58 66.87 -226.05 -129.58 66.87 -226.05 -129.58
Equity 91.04 64.11 42.01 91.04 64.11 42.01 91.04 64.11 42.01
PBIDTM(%) 11.78 14.23 -17.20 11.78 14.23 -17.20 11.78 14.23 -17.20
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..